Biotech · Private company
Ablacon, Inc.
Track this companyFree. Adds Ablacon, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Electrographic Flow™ (EGF) mapping and ablationAtrial Fibrillation, PersistentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.NA · ACTIVE_NOT_RECRUITING · started Oct 23, 2023ClinicalTrials.gov NCT05883631 · fetched Nov 12, 2026
- AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial FibrillationCOMPLETED · started Sep 12, 2022ClinicalTrials.gov NCT05481359 · fetched Nov 12, 2026